The CASCADE Project

Cancer Clinical Trial

— CASCADE  

Official title:

Co-design of Acute Oncology Standardised Assessment Documents and Their Evaluation

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06117592
• Other study ID #: cftsp227
• Status: Not yet recruiting
• Start date: March 1, 2024
• Est. completion date: March 29, 2024

Study information

• Verified date: February 2024
• Source: The Christie NHS Foundation Trust
• Contact: Verna TC Lavender, PhD
• Phone: 07773664761
• Email: Verna.Lavender[@]gstt.nhs.uk
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

People with cancer, treated for cancer, or have been recently treated for cancer are at a higher risk of becoming rapidly unwell. This is referred to as an oncological emergency and can be life-threatening.

The investigators want to see if a new, standardised assessment of acute oncology knowledge and skills of all health care staff (The Acute Oncology Passport) following education and training, has an effect on the diagnosis and treatment of two relatively-common oncological emergencies: sepsis and MSCC? Sepsis is blood poisoning, which causes serious injuries if it is not diagnosed and treated as an emergency and may result in death if not treated quickly enough. MSCC is metastatic spinal cord compression, where the cancer presses on the spinal cord and can cause permanent paralysis. The investigators have chosen these two conditions, not only because of how serious and relatively common they are for people living with cancer, but also because all NHS Trusts in the UK routinely collect and report standardised data about patients who are admitted with suspected sepsis or MSCC.

The investigators plan to compare data that is routinely collected about the diagnosis and treatment of patients with suspected sepsis and MSCC before and after education, training and assessment of staff about acute oncology. The investigators will conduct 'secondary analysis' on the data, as it was originally collected for another purpose. The routinely data collected at five hospital Trusts across the UK from 1st April 2023 to 30th June 2023 and 1st October to 31st December 2023 will be included in this study.

This research is part of a larger UK-wide project, funded until March 2024 by NHS England Workforce, Training and Education Directorate. If acute oncology education, training and assessment of staff is shown to make a difference to patient diagnosis and treatment, the Acute Oncology Passports will be rolled-out nationally.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1400
• Est. completion date: March 29, 2024
• Est. primary completion date: March 29, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patient KPI's of interest that occur in the study time frame will be collected.

Exclusion Criteria:

• KPI data collected from people under the age of 18 KPI data other than items stated in this application, i.e. data that is not reporting neutropenic sepsis nor MSCC outcomes

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Education, training and assessment intervention
Staff competence assessment documents for acute oncology knowledge and skills

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
The Christie NHS Foundation Trust

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acute Oncology Key Performance Indicators (KPIs)	These are routinely collected metrics by acute oncology teams for patients presenting with suspected neutropenic sepsis or metastatic spinal cord compression.	1st April 2023- 31st December 2023